-
Congratulations to Dr. Doug Lowy and Dr. John Schiller
-
Steven Cappell appointed as new Stadtman Investigator
-
Clinical trial will investigate targeted radionuclide therapy for inoperable rare tumors
-
Clinical trial aims to study immunotherapy for central nervous system tumors
-
-
RT @theNCI: CAR T-cell therapy approved for some children and young adults with leukemia https://t.co/ei0NRwvEst #immunotherapy… https://t.co/uAYOMpVECt
-
Defne Bayik Watson (Turkey), Cancer & Inflammation Program, explains why @theNCI @NIH is the best place to do resea… https://t.co/CtR7wdao4b
-
We are proud of @rosiekaplanmd and her team also! #NPAW2017 https://t.co/PkcGwm9Qyn
-
#CCRAdvance exciting data now out in @NatureMedicine from @rosiekaplanmd et al. https://t.co/yIE47TFZd4
-
#CCRAdvance from Robert Yarchoan et al #Lymphoma awareness month https://t.co/t5FaJ8Gkit
-
Join @NCItreatment @NCIResearchCtr & @lymphoma for a Twitter chat on Lymphoma treatment in young people #PedAYAChat… https://t.co/ZsVlC3obF0
-
RT @postlive: Dr. Nirali Shah of @theNCI tells @lauriemcginley2 about the effectiveness of CAR T-cell therapy #PostLive… https://t.co/WSfsCwWAD9
